Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial

被引:15
作者
Haifeng Zhang
Yajun Lian
Yunqing Ma
Yuan Chen
Caihong He
Nanchang Xie
Chuanjie Wu
机构
[1] Zhengzhou University,Department of Neurology, the First Affiliated Hospital
来源
The Journal of Headache and Pain | 2014年 / 15卷
关键词
Botulinum toxin type A; Trigeminal neuralgia; Double-blind; Placebo-controlled treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 98 条
[1]
Campos WK(2004)The International Classification of Headache Disorders: 2nd edition Cephalalgia 24 9-160
[2]
Linhares MN(2011)A prospective study of 39 patients with trigeminal neuralgia treated with percutaneous balloon compression Arq Neuropsiquiatr 69 221-226
[3]
Turp JC(2000)Trigeminal neuralgia--an update Compend Contin Educ Dent 21 279-282
[4]
Gobetti JP(2011)Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain Postgrad Med J 87 410-416
[5]
Zakrzewska JM(2012)Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition J Headache Pain 13 S1-S29
[6]
McMillan R(2012)Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial Cephalalgia 32 443-450
[7]
Bendtsen L(2011)Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm Turk Neurosurg 21 625-629
[8]
Birk S(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 793-803
[9]
Kasch H(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 804-814
[10]
Aegidius K(2010)Botulinum toxin in headache treatment: finally a promising path Cephalalgia 30 771-773